Crossmark

Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes

Crossref DOI link: https://doi.org/10.1007/s13346-018-0560-2

Published Online: 2018-07-16

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sabatino, Raffaella

Battistelli, Serafina

Magnani, Mauro

Rossi, Luigia
License Information

Text and Data Mining valid from 2018-07-16
More Information

Article History

First Online: 16 July 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All institutional and national guidelines for the care and use of laboratory animals were followed.